Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma

BACKGROUND: The potential of circulating tumour DNA (ctDNA) as a reliable biomarker for relapse/metastasis early detection and prognosis in esophageal squamous cell carcinoma (ESCC) after radiotherapy/chemoradiotherapy (RT/CRT) initiation requires comprehensive investigation. METHODS: Treatment‐naiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Yu, Nuo, Cheng, Guowei, Zhang, Tao, Wang, Jianyang, Deng, Lei, Li, Jiao, Zhao, Xiaotian, Xu, Yang, Yang, Peng, Bai, Na, Li, Yin, Bi, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702363/
https://www.ncbi.nlm.nih.gov/pubmed/36437506
http://dx.doi.org/10.1002/ctm2.1116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702363/
https://www.ncbi.nlm.nih.gov/pubmed/36437506
http://dx.doi.org/10.1002/ctm2.1116

Ejemplares similares